GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TheraCryf PLC (LSE:TCF) » Definitions » FFO

TheraCryf (LSE:TCF) FFO


View and export this data going back to 2015. Start your Free Trial

What is TheraCryf FFO?

FFO (Funds from operations) only applies to REITs.


TheraCryf Business Description

Traded in Other Exchanges
N/A
Address
Congleton Road, Alderley Park, Nether Alderley, Cheshire, GBR, SK10 4TG
TheraCryf PLC is a clinical-stage biotechnology company focused on profitable segments in oncology and neuropsychiatry. The company's lead clinical asset, SFX-01 is a patented form of delivering sulforaphane, which could be used in the treatment of a number of cancers, neurodevelopmental disorders, and other diseases.